These mutated genes are common oncogenes in TGCTs and primarily promote tumor progression by activating the PI3K-AKT and RAS-MAPK signaling pathways, which stimulate cell proliferation or inhibit apoptosis.38 This evidence concerns the gene AKT1 and neoplasm.